Nu Skin Enterprises earnings release, May 7, 2026

Nu Skin Enterprises, Inc. (NUS) · Form 8-K, Item 2.02 · Filed · SEC filing

Nu Skin Enterprises Reports First Quarter Results

PROVO, Utah — May 7, 2026 — Nu Skin Enterprises Inc.

(NYSE: NUS) today announced first quarter revenue results within its guidance range.

Executive Summary

Q1 2026 vs. Prior-year Quarter

“We delivered first quarter revenue in line with our expectations and made further progress in our strategic priorities while operating in a volatile environment,” said

Ryan Napierski, Nu Skin president and CEO. “As we move through 2026, we are focused on empowering our sales leaders to scale our intelligent wellness platform with our latest innovation, Prysm iO™, ahead of our full consumer rollout in the second half. We also continue to invest in laying the groundwork to expand our presence in emerging markets, including the formal launch of India anticipated in late 2026, while continuing to improve our operational discipline to return value to shareholders.

“We are encouraged by early signs of improving paid affiliates and new sales leader development in several markets as our leaders begin integrating Prysm iO into their businesses and continue to build upon our leading anti-aging Tru Face® brand. We are focused on partnering with our sales force on leveraging the proprietary nutritional health biomarker tracking from Prysm iO to expand the channel as we prepare to drive customer subscriptions for our wellness products. While these initiatives will take time to develop, we remain confident that they will increase sales leader engagement and expand our global reach over time to drive the next phase of growth for

Nu Skin.”

Q1 2026 Year-over-year Operating Results

Stockholder Value

Q2 and Full-year 2026 Outlook

“In addition to delivering on revenue and adjusted earnings, we returned $8 million to shareholders in the form of dividends and share repurchases,” said Chelsea Lantz, interim chief financial officer. “We were also able to refinance our debt, extending our liquidity as we invest in growth initiatives and navigate market volatility while executing on our strategy.

We are maintaining our annual guidance for 2026 on an adjusted basis. For the second quarter, we project revenue between $330 million and $360 million, with earnings per share in the range of $0.15 to $0.25.”

Conference Call

The Nu Skin Enterprises management team will host a conference call with the investment community today at 5 p.m. (ET). Those wishing to access the webcast, as well as the financial information presented during the call, can visit the Investor Relations page on the company’s website at ir.nuskin.com. A replay of the webcast will be available on the same page through May 21, 2026.

About Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc.

(NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

Financial statements

Income Statement

Q1 2026 Year-over-year Operating Results

$320.6 million compared to $364.5 million • +1.1% FX impact or $3.9 million – 66.9% or 67.9% excluding certain charges compared to 67.8% • Nu Skin business was 76.9% compared to 76.7% – 34.3% compared to 32.5% • Nu Skin business was 40.5% compared to 38.7% – 30.7% or 29.9% excluding certain charges compared to 31.1% or 28.9% excluding certain charges – $1.8 million impairment compared to $25.1 million impairment – 1.3% or 3.6% excluding certain charges compared to (2.7)% or 6.4% excluding impairment and other charges
Interest Expense$4.3 million compared to $3.3 million
Other Income (Expense)$2.8 million compared to $(28.4) million • Prior year reflects $28.1 million unrealized loss on investment
Income Tax Rate29.4% compared to 20.1%
EPS$0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale and other charges

Income Statement

Three Months Ended March 31, — (U.S. dollars in thousands, except per share amounts)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Revenue320,608364,490
Cost of sales106,145117,529
Gross profit214,463246,961
Operating expenses:Selling expenses110,054118,546
Operating expenses:General and administrative expenses98,544113,204
Operating expenses:Impairment expenses1,83925,114
Operating expenses:Total operating expenses210,437256,864
Operating expenses:Operating income (loss)4,026-9,903
Operating expenses:Interest expense4,2503,283
Operating expenses:Gain on sale of business176,162
Operating expenses:Other income (expense), net2,823-28,375
Operating expenses:Income before provision for income taxes2,599134,601
Operating expenses:Provision for income taxes76327,086
Operating expenses:Net income1,836107,515
Net income per share:Basic0.042.16
Net income per share:Diluted0.042.14
Weighted-average common shares outstanding (000s):Basic48,20249,764
Weighted-average common shares outstanding (000s):Diluted49,42250,328

Income Statement

Three months ended March 31, — (in thousands, except for per share amounts)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Gross profit214,463246,961
Impact of inventory write-off3,116
Adjusted gross profit217,579246,961
Gross margin66.9%67.8
Gross margin, excluding inventory write-off impact67.9%67.8
Revenue320,608364,490

Income Statement

Three months ended March 31, — (in thousands, except for per share amounts)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Operating income (loss)4,026-9,903
Impact of inventory write-off3,116
Impact of other charges(1)2,6437,966
Impact of impairment1,83925,114
Adjusted operating income11,62423,177
Operating margin1.3%-2.7%
Operating margin, excluding certain charges3.6%6.4%
Revenue320,608364,490

Income Statement

Three months ended March 31, — (in thousands, except for per share amounts)

Three months ended March 31, – 2026Three months ended March 31, – 2025
Net income1,836107,515
Impact of inventory write-offInventory write-off3,116
Impact of inventory write-offTax impact-1,065
Impact of other charges:Other charges(1)2,6437,966
Impact of other charges:Tax impact-903-725
Impact of impairment expense:Impairment1,83925,114
Impact of impairment expense:Tax impact-629-5,433
Impact of Mavely saleGain from Mavely sale-176,162
Impact of Mavely saleTax impact31,104
Impact of unrealized investment lossUnrealized investment loss28,077
Impact of unrealized investment lossTax impact-6,074
Impact of unrealized investment lossAdjusted net income6,83711,382
Impact of unrealized investment lossDiluted earnings per share0.042.14
Impact of unrealized investment lossDiluted earnings per share, excluding restructuring impact0.140.23
Impact of unrealized investment lossWeighted-average common shares outstanding (000)49,42250,328

Balance Sheet

December 31, — (U.S. dollars in thousands)

March 31, – 2026December 31, – 2025
Current assets:Cash and cash equivalents198,654238,630
Current assets:Current investments1,7511,211
Current assets:Accounts receivable, net45,01339,544
Current assets:Inventories, net178,600178,643
Current assets:Prepaid expenses and other98,87089,670
Current assets:Total current assets522,888547,698
Current assets:Property and equipment, net381,610377,168
Current assets:Operating lease right-of-use assets70,35074,021
Current assets:Goodwill83,62583,625
Current assets:Other intangible assets, net39,29042,614
Current assets:Other assets279,035280,187
Current assets:Total assets1,376,7981,405,313
Current liabilities:Accounts payable28,81526,183
Current liabilities:Accrued expenses208,182217,551
Current liabilities:Current portion of long-term debt20,00020,000
Current liabilities:Total current liabilities256,997263,734
Current liabilities:Operating lease liabilities54,01757,640
Current liabilities:Long-term debt203,593204,187
Current liabilities:Other liabilities68,10474,512
Current liabilities:Total liabilities582,711600,073
Stockholders’ equity:Class A common stock – 500 million shares authorized, $0.001 par value, 90.6 million shares issued9191
Stockholders’ equity:Additional paid-in capital613,890635,994
Stockholders’ equity:Treasury stock, at cost – 42.0 million and 42.4 million shares-1,560,799-1,575,059
Full release

Important Information Regarding Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company’s current expectations and beliefs. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws and include, but are not limited to, statements of management’s expectations regarding the company’s performance, growth, initiatives, plans, areas of focus, sales force and customers, shareholder value, Prysm launch and its timing and potential benefits to the business, and emerging market expansion and its timing; projections regarding revenue, expenses, margins, tax rates, earnings per share, foreign currency fluctuations, uses of cash, financial position and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as “believe,” “expect,” “become,” “continue,” “project,” “outlook,” “guidance,” “focus,” “expand,” “will,” “would,” “could,” “may,” “might,” the negative of these words and other similar words.

The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:

The company’s financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company’s beliefs as of the date that such information was first provided, and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.

Non-GAAP Financial Measures:... (truncated)impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the company’s performance. It is calculated by translating the current period’s revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period’s revenue. The company believes that constant-currency revenue change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company’s revenue from period to period.

Earnings per share, gross margin, general and administrative expenses, and operating margin, each excluding inventory write-off charges, impairment expense, the gain from the Mavely sale, unrealized investment loss, and/or other charges, also are non-GAAP financial measures.

The company believes that these non-GAAP financial measures are useful to investors, lenders and analysts because removing the impact of these items facilitates period-to-period comparisons of the company’s performance. Please see the reconciliations of these items to our earnings per share, gross margin, operating margin, income tax rate and revenue growth rate calculated under GAAP, below.

The following table sets forth revenue for the three-month periods ended March 31, 2026, and 2025 for each of our reportable segments (U.S. dollars in thousands):

The following table provides information concerning the number of Customers, Paid Affiliates and Sales Leaders in our core Nu Skin business for the three-month periods ended March 31, 2026 and 2025:

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Income (Unaudited)

(U.S. dollars in thousands, except per share amounts)

NU SKIN ENTERPRISES, INC.

Consolidated Balance Sheets (Unaudited)

(U.S. dollars in thousands)

NU SKIN ENTERPRISES, INC.

Reconciliation of Gross Margin Excluding Impact of Inventory Write-off to GAAP Gross Margin

(in thousands, except for per share amounts)

NU SKIN ENTERPRISES, INC.

Reconciliation of General and Administrative Expenses Excluding Certain Charges to GAAP General and Administrative Expenses

(in thousands, except for per share amounts)

(1)

Other charges for the first quarter of 2026 consist of $1.0 million related to the wind down of the separate BeautyBio business and $1.6 million of other employee severance charges. Other charges for the first quarter of 2025 consist of expenses incurred in connection with the Mavely sale, including $2.7 million of transaction bonuses for certain employees and $5.2 million of equity compensation as a result of the vesting of the Mavely profits interest units.

NU SKIN ENTERPRISES, INC.

Reconciliation of Operating Margin Excluding Certain Charges to GAAP Operating Margin

(in thousands, except for per share amounts)

NU SKIN ENTERPRISES, INC.

Reconciliation of Earnings Per Share Excluding Impact of Certain Charges to GAAP Earnings Per Share

(in thousands, except for per share amounts)

NU SKIN ENTERPRISES, INC.

Reconciliation of Earnings Per Share Excluding Impact of Certain Charges to GAAP Earnings Per Share

# # #

CONTACTS:

Media: media@nuskin.com, (801) 345-6397

Investors: investorrelations@nuskin.com, (801) 345-3577

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Nu Skin Enterprises earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.